Table 1.
Summary of reported characteristics of oral CTCL
| Number of cases with oral MF | 76 |
| Sex (n = 65) | Total (%) |
| Male | 40 (62) |
| Female | 25 (38) |
| Male:female | 1.6:1 |
| Race, n | |
| Caucasian | 17 |
| African American | 2 |
| Other | 1 |
| Unknown | 56 |
| Age (n = 64) | |
| Mean in years (range) | 57.8 (12–85) |
| CTCL type | Total (%) |
| MF | 57 (75) |
| CD4+CD8+ | 8 (10) |
| Transformed MF | 6 (8) |
| Sézary Syndrome | 3 (4) |
| CD4−CD8− | 2 (3) |
| Areas of involvement, n | |
| Tongue | 37 |
| Palate | 35 |
| Gingiva | 19 |
| Buccal mucosa | 16 |
| Tonsils | 12 |
| Pharynx | 10 |
| Esophagus | 9 |
| Larynx | 7 |
| Trachea | 5 |
| Uvula | 4 |
| Vestibule | 2 |
| Alveolar ridge | 2 |
| Primary lesion morphology, n | |
| Tumor | 23 |
| Plaque | 17 |
| Nodule | 8 |
| Papule | 1 |
| Secondary lesion characteristics, n | |
| Erythema | 17 |
| Ulcer | 25 |
| Firm | 9 |
| Edema | 7 |
| Erosion | 6 |
| Pseudomembrane | 5 |
| Necrosis | 4 |
| Soft/boggy | 4 |
| Leukoplakia | 3 |
| Perforation | 1 |
| Mobile | 1 |
| Gangrenous | 1 |
| Eruption | 1 |
| Fungating | 1 |
| Associated symptoms, n | |
| Dysphagia | 14 |
| Pain | 11 |
| Glossitis | 7 |
| Odynophagia | 5 |
| Hoarseness | 1 |
| Asymptomatic | 2 |
| Burning sensation | 2 |
| Painless | 2 |
| Difficulty in speaking | 1 |
| Nasal regurgitation | 1 |
| Length of time for oral CTCL to present from initial cutaneous lesions (n = 52) | |
| Mean in years (range) | 6.4 years |
| Range | 2 months −30 years |
| Outcome (n = 51) | Total (%) |
| Death | 34 (67) |
| Alive | 17 (33) |
| Causes of death (n = 33) | Total (%) |
| Sepsis | 14 (42) |
| Advanced disease | 11 (33) |
| Unknown | 5 (15) |
| Other | 3 (9) |
| Length of time from initial oral lesion to death (n = 30) | |
| Mean in months (range) | 13.2 (0.5–48) |
MF, mycosis fungoides.